SCHEMBL7059979

SCHEMBL7059979

CC(CCNC(=O)c1ccc(-c2csc(-c3ccncc3)n2)cc1)C(CC#N)C(N)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.47
NPC1 O15118 8/20 0.47
SMN1; SMN2 Q16637 8/20 0.47
KDM4E B2RXH2 7/20 0.47
MAPT P10636 4/20 0.47
ALDH1A1 P00352 3/20 0.47
HPGD P15428 2/20 0.47
POLB P06746 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
AGTR1 P30556 1/20 0.47
HTT P42858 1/20 0.47
EIF4E P06730 3/20 0.41
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
LMNA P02545 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
CTSB P07858 3/20 0.39
CTSS P25774 3/20 0.39
CTSL P07711 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6183464 0.80 NPC1 (0.48) RAB9ANPC1SMN1; SMN2KDM4EMAPT
SCHEMBL6185260 0.73 NPC1 (0.49) RAB9ANPC1SMN1; SMN2KDM4EMAPT
SCHEMBL7060328 0.72 RAB9A (0.47) RAB9ANPC1SMN1; SMN2KDM4EMAPT
SCHEMBL6183458 0.72 CTSB (0.63) RAB9ANPC1SMN1; SMN2KDM4EMAPT
SCHEMBL16964146 0.72 KDM4E (0.54) RAB9ANPC1SMN1; SMN2KDM4EMAPT
SCHEMBL6184482 0.72 RAB9A (0.51) RAB9ANPC1SMN1; SMN2KDM4EMAPT
SCHEMBL6185266 0.70 RAB9A (0.46) RAB9ANPC1SMN1; SMN2KDM4EMAPT
SCHEMBL6182545 0.70 CTSB (0.75) CTSBCTSSCTSL
SCHEMBL6183646 0.70 PARP1 (0.52) SMN1; SMN2KDM4EMAPTALDH1A1HPGD
SCHEMBL6183920 0.70 NPC1 (0.45) RAB9ANPC1SMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6593327-B2 N-cyanomethyl amides which are cysteine protease inhibitors; treating osteoporosis; mixtures with bisphosphonates AXYS PHARMACEUTICALS, INC. 2003-07-15 US disclosed